Delivery Order SPE2DB20D2104-SPE2DB25FNBFD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,128.26 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 7, 2025, just one day after the award date of August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.72 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.50 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilized firm fixed pricing under a non-set-aside, competitive procurement process. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,706.63 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract is firm fixed price with a completion date of September 16, 2025, and represents a non-competitive set-aside award. Performance of this delivery order will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $21,445.91 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, with performance in Conshohocken, Pennsylvania and completion targeted for September 15, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed on September 12, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,643.52 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive award, issued on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,287.23 firm fixed price delivery order is for the provision of 4,564,085,519 units of the antibiotic medication Fosfomycin 3 GM Sachets. The award is associated with a larger indefinite delivery contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,146.64, is for the delivery of 4,567,909,932 units of Fosfomycin 3 GM Sachets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, a pharmaceutical product. The contract has a firm fixed price of $1,291.85 and a completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and federal healthcare providers nationwide. The contract is not set aside for...
- The Defense Logistics Agency awarded a $248,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 3 gram sachets of fosfomycin. As a prime contractor on the Agency's Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle, Amerisourcebergen will supply the antibiotic medication to DLA distribution points in Conshohocken, Pennsylvania from August 24-25, 2023. No subcontractors or set aside designations were specified. This supports DLA's mission to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBFDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,798.03 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive, non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes a firm fixed price structure, reflecting a straightforward pharmaceutical procurement for military healthcare needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including products for the Defense Health Agency and U.S. Coast Guard. The company's federal procurement portfolio demonstrates consistent capability in meeting competitive bidding requirements for diverse pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/23/25 |